meRfi®-GM
Candida albicans / Candida albicans infection
Welcome to meRfi-GM!
meRfi-GM provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
Navigation
Contents
70% - 80% of healthy patients experienced S. aureus, C. albicans, and cytomegalovirus infections
Lu et al. 2021 Curr Opin Immunol 72: 1-12
Colonization resistance is a non-specific defense mechanism. It limits the growth of C. albicans in the large intestine. This keeps the opportunist's abundance low in feces.
[Disruption of the gut microbiota](brain://ttq0…
References (Sources)
- Excess mortality, hospital stay, and cost due to candidemia: A case-control study using data from population-based candidemia surveillance
- High-resolution mycobiota analysis reveals dynamic intestinal translocation preceding invasive candidiasis
- Host control of fungal infections: lessons from basic studies and human cohorts
- Invasive candidiasis
- Prevalence of vulvovaginal candidiasis and susceptibility to fluconazole in women
- Th17 cells confer long-term adaptive immunity to oral mucosal Candida albicans infections
- Vulvovaginal candidosis